InvestorsHub Logo

Jimmy Joe

11/08/15 1:49 AM

#171147 RE: henryz8th #171134

2016 will be good. I think 2017 will be the year to watch.

Epic will also be something to watch.

Epic entering the prescription opioid sector with oxycodone while also doing manufacturing of generics for Elite. Don't those watching this kind of feel it strange that Epic is going to be manufacturing oxycontin at the same time Elite is coming out with ELI-200?

Could be more than a partnership here brewing. Call it a midsized
ready made pharmaceutical company. Lots of generics... lots of manufacturing ability to make both generics and ADF opioids.

I know we have been down this road many times before but it is looking more like a perfect fit for both companies which already work well together.